In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Day One Biopharmaceuticals Inc (NASDAQ: DAWN) was $14.85 for the day, up 1.64% from the previous closing price of $14.61. In other words, the price has increased by $1.64 from its previous closing price. On the day, 0.8 million shares were traded. DAWN stock price reached its highest trading level at $15.29 during the session, while it also had its lowest trading level at $14.55.
Ratios:
Our analysis of DAWN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.72 and its Current Ratio is at 12.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 25, 2023, Downgraded its rating to Underperform and sets its target price to $9 from $34 previously.
On February 08, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 25 ’24 when Blackman Samuel C. sold 10,000 shares for $16.01 per share. The transaction valued at 160,055 led to the insider holds 1,184,662 shares of the business.
Blackman Samuel C. sold 30,000 shares of DAWN for $457,314 on Mar 11 ’24. The HEAD OF R&D now owns 1,194,662 shares after completing the transaction at $15.24 per share. On Feb 27 ’24, another insider, Blackman Samuel C., who serves as the HEAD OF R&D of the company, sold 20,000 shares for $16.11 each. As a result, the insider received 322,166 and left with 1,224,662 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1297551488 and an Enterprise Value of 931726080.
Stock Price History:
The Beta on a monthly basis for DAWN is -1.38, which has changed by 0.14230764 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, DAWN has reached a high of $17.85, while it has fallen to a 52-week low of $9.67. The 50-Day Moving Average of the stock is -2.40%, while the 200-Day Moving Average is calculated to be 10.58%.
Shares Statistics:
DAWN traded an average of 641.01K shares per day over the past three months and 713400 shares per day over the past ten days. A total of 87.23M shares are outstanding, with a floating share count of 58.94M. Insiders hold about 32.55% of the company’s shares, while institutions hold 76.22% stake in the company. Shares short for DAWN as of 1711584000 were 8984718 with a Short Ratio of 14.02, compared to 1709164800 on 9703479. Therefore, it implies a Short% of Shares Outstanding of 8984718 and a Short% of Float of 12.83.
